Treatment of Experimental Autoimmune Encephalomyelitis by Sustained Delivery of Low-Dose IFN-α

Marcos Vasquez,Marta Consuegra-Fernández,Fernando Aranda,Aitor Jimenez,Shirley Tenesaca,Myriam Fernandez-Sendin,Celia Gomar,Nuria Ardaiz,Claudia Augusta Di Trani,Noelia Casares,Juan Jose Lasarte,Francisco Lozano,Pedro Berraondo
DOI: https://doi.org/10.4049/jimmunol.1801462
2019-06-17
The Journal of Immunology
Abstract:Key Points<p><li><p>Recombinant adeno-associated virus expresses low and sustained levels of IFN-α.</p></li><li><p>AAV–IFN-α exerts a potent therapeutic effect and low toxicity in an EAE animal model.</p></li></p>
What problem does this paper attempt to address?